NM 100080
Alternative Names: NM-02012; NM-100080Latest Information Update: 11 Feb 2008
At a glance
- Originator NexMed
- Class Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pressure ulcer; Wounds
Most Recent Events
- 30 Aug 2005 NM 100080 is available for partnering (http://www.nexmed.com)
- 17 Jul 2003 Clinical trials in Decubitus ulcer in USA (Topical)